| Heart Failure (HF) |
1 |
1 |
| Clinical Guidelines |
0 |
0.8 |
| Cardiomyopathy |
0 |
0.78 |
| Acute Heart Failure (HF) |
0 |
0.77 |
| Hypertension |
0 |
0.75 |
| Cardiovascular Imaging |
0 |
0.61 |
| Atrial Fibrillation |
0 |
0.55 |
| Heart |
0 |
0.47 |
| Coronary Artery Disease (CAD) |
0 |
0.4 |
| Valvular Heart Disease |
0 |
0.37 |
| Heart Transplantation |
0 |
0.34 |
| Otolaryngology |
0 |
0.26 |
| Type 2 Diabetes Mellitus |
0 |
0.2 |
| Washington |
0 |
0.19 |
| Receptors |
0 |
0.14 |
| SGLT2 Inhibitor |
0 |
0.14 |
| Angiotensin II Receptor Blockade |
0 |
0.13 |
| Pregnancy |
0 |
0.12 |
| Urticaria and Angioedema |
0 |
0.12 |
| Genomic Medicine |
0 |
0.11 |
| ACE Inhibitor |
0 |
0.09 |
| Ejection Fraction |
0 |
0.09 |
| Obesity |
0 |
0.07 |
| Sleep Apnea |
0 |
0.07 |
| Sleep Disorders |
0 |
0.07 |
| Angioedema |
0 |
0.05 |
| Angioneurotic Edema |
0 |
0.05 |
| Artery |
0 |
0.05 |
| Beta Blockers |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Board Certification |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Chemotherapy |
0 |
0.05 |
| Cough |
0 |
0.05 |
| Exercise |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Interprofessional Continuing Education |
0 |
0.05 |
| Left Ventricular Dysfunction |
0 |
0.05 |
| Primary Care |
0 |
0.05 |
| Quality of Life |
0 |
0.05 |
| Renin-Angiotensin System |
0 |
0.05 |
| Sleep |
0 |
0.05 |
| Transplantation |
0 |
0.05 |